These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21483009)

  • 21. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
    Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
    Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
    Tabernero J; Van Cutsem E; Díaz-Rubio E; Cervantes A; Humblet Y; André T; Van Laethem JL; Soulié P; Casado E; Verslype C; Valera JS; Tortora G; Ciardiello F; Kisker O; de Gramont A
    J Clin Oncol; 2007 Nov; 25(33):5225-32. PubMed ID: 18024868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successes in late solid tumors. New therapy offer].
    Arnheim K
    MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
    [No Abstract]   [Full Text] [Related]  

  • 24. First- and second-line therapy of metastatic colorectal cancer.
    Terstriep S; Grothey A
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study.
    Pessaux P; Panaro F; Casnedi S; Zeca I; Marzano E; Bachellier P; Jaeck D; Chenard MP
    Eur J Surg Oncol; 2010 Jun; 36(6):575-82. PubMed ID: 20452168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version.
    Zalinski S; Mariette C; Farges O; ; ;
    J Visc Surg; 2011 Jun; 148(3):e171-82. PubMed ID: 21703959
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of resection of synchronous multiple liver metastases from colorectal cancer after hepatic infusion chemotherapy and systemic chemotherapy].
    Sagawa T; Sato Y; Takayama T; Hirakawa M; Abe S; Iyama S; Miyanishi K; Kawano Y; Takada K; Nakamura T; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1481-4. PubMed ID: 17876151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
    Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
    Mohammed TA; Dennie T; Holen KD
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 32. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
    Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
    [No Abstract]   [Full Text] [Related]  

  • 33. Bevacizumab in the treatment of colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
    [No Abstract]   [Full Text] [Related]  

  • 34. Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancer.
    Afonso S; Viani G; Afonso V; Stefano E; Afonso S
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S21-3. PubMed ID: 21768794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
    Braiteh F; Kurzrock R; Johnson FM
    J Clin Oncol; 2008 Jul; 26(20):3460-2. PubMed ID: 18612164
    [No Abstract]   [Full Text] [Related]  

  • 36. Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients.
    Altundag K; Silay YS; Altundag O; Yigitbasi OG; Gundeslioglu O; Gunduz M
    Med Hypotheses; 2005; 64(6):1162-5. PubMed ID: 15823708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive trichomegaly.
    Vano-Galvan S; Moreno-Martin P; Jaén P
    Neth J Med; 2009 Jan; 67(1):35-6. PubMed ID: 19155549
    [No Abstract]   [Full Text] [Related]  

  • 38. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
    Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN
    J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793
    [No Abstract]   [Full Text] [Related]  

  • 39. Trichomegaly of the eyelashes following treatment with cetuximab.
    Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
    Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
    [No Abstract]   [Full Text] [Related]  

  • 40. Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.
    Simkens L; Tol J; Koopman M; Mol L; Antonini N; van Krieken H; Punt C
    Clin Colorectal Cancer; 2008 Mar; 7(2):105-9. PubMed ID: 18501069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.